Literature DB >> 22850307

The Quick Inventory of Depressive Symptomatology, clinician rated and self-report: a psychometric assessment in Chinese Americans with major depressive disorder.

Albert Yeung1, Gregory Feldman, Paola Pedrelli, Kate Hails, Maurizio Fava, Tracy Reyes, James C Mundt.   

Abstract

This study aimed to investigate the psychometric properties of the Chinese translations of the Quick Inventory of Depressive Symptomatology (QIDS(16)), including the Clinician-Rated (QIDS-C(16)), Self-report (QIDS-SR(16)), and Interactive Voice Response (QIDS-SR-IVR(16)) formats. Thirty depressed Chinese Americans were assessed with Chinese translations of the QIDS-SR(16), QIDS-SR-IVR(16), and QIDS-C(16). Cronbach alpha estimates of internal scale consistency on the QIDS-SR(16), QIDS-SR-IVR(16), and QIDS-C(16) were 0.70, 0.74, and 0.79, respectively. Intercorrelations among the measures were QIDS-SR(16) and QIDS-SR-IVR(16), r = 0.79; QIDS-SR(16) and QIDS-C(16), r = 0.61; and QIDS-SR-IVR(16) and QIDS-C(16), r = 0.69 (all p values < 0.01). The areas under the curve for the receiver operating characteristics of the QIDS-SR(16) and QIDS-SR-IVR(16) were 0.78 (95% confidence interval, 0.61-0.95) and 0.81 (95% confidence interval, 0.65-0.96), respectively. The respective screening sensitivities/specificities were 0.73/0.74 and 0.86/0.58. The Chinese translations of the QIDS(16) have adequate psychometric properties and may be useful tools for depression screening.

Entities:  

Mesh:

Year:  2012        PMID: 22850307      PMCID: PMC3762496          DOI: 10.1097/NMD.0b013e318261413d

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  17 in total

Review 1.  Depressive disorders in Asian American adults.

Authors:  Jian-Ping Chen; Hongtu Chen; Henry Chung
Journal:  West J Med       Date:  2002-09

2.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

3.  Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.

Authors:  Madhukar H Trivedi; A John Rush; Bradley N Gaynes; Jonathan W Stewart; Stephen R Wisniewski; Diane Warden; Louise Ritz; James F Luther; Diane Stegman; Joanne Deveaugh-Geiss; Robert Howland
Journal:  Neuropsychopharmacology       Date:  2007-04-04       Impact factor: 7.853

4.  An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

Authors:  A John Rush; Ira H Bernstein; Madhukar H Trivedi; Thomas J Carmody; Stephen Wisniewski; James C Mundt; Kathy Shores-Wilson; Melanie M Biggs; Ada Woo; Andrew A Nierenberg; Maurizio Fava
Journal:  Biol Psychiatry       Date:  2005-09-30       Impact factor: 13.382

5.  Recognizing and engaging depressed Chinese Americans in treatment in a primary care setting.

Authors:  Albert Yeung; Shu-Ching Yu; Freddy Fung; Sienna Vorono; Maurizio Fava
Journal:  Int J Geriatr Psychiatry       Date:  2006-09       Impact factor: 3.485

6.  Culturally sensitive collaborative treatment for depressed chinese americans in primary care.

Authors:  Albert Yeung; Irene Shyu; Lauren Fisher; Shirley Wu; Huaiyu Yang; Maurizio Fava
Journal:  Am J Public Health       Date:  2010-10-21       Impact factor: 9.308

7.  Diagnostic utility of the Quick Inventory of Depressive Symptomatology (QIDS-C16 and QIDS-SR16) in the elderly.

Authors:  P Murali Doraiswamy; I H Bernstein; A J Rush; Y Kyutoku; T J Carmody; L Macleod; S Venkatraman; M Burks; D Stegman; B Witte; M H Trivedi
Journal:  Acta Psychiatr Scand       Date:  2010-01-19       Impact factor: 6.392

8.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

Authors:  A John Rush; Madhukar H Trivedi; Hicham M Ibrahim; Thomas J Carmody; Bruce Arnow; Daniel N Klein; John C Markowitz; Philip T Ninan; Susan Kornstein; Rachel Manber; Michael E Thase; James H Kocsis; Martin B Keller
Journal:  Biol Psychiatry       Date:  2003-09-01       Impact factor: 13.382

9.  Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans.

Authors:  Albert Yeung; Freddy Fung; Shu-Ching Yu; Sienna Vorono; Mary Ly; Shirley Wu; Maurizio Fava
Journal:  Compr Psychiatry       Date:  2007-10-24       Impact factor: 3.735

10.  Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome.

Authors:  Nagisa Sugaya; Shinobu Nomura
Journal:  Biopsychosoc Med       Date:  2008-04-08
View more
  6 in total

1.  Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial.

Authors:  Philip Cheng; Annemarie I Luik; Cynthia Fellman-Couture; Edward Peterson; Christine L M Joseph; Gabriel Tallent; Kieulinh Michelle Tran; Brian K Ahmedani; Timothy Roehrs; Thomas Roth; Christopher L Drake
Journal:  Psychol Med       Date:  2018-05-24       Impact factor: 7.723

2.  Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial.

Authors:  Philip Cheng; David A Kalmbach; Gabriel Tallent; Christine Lm Joseph; Colin A Espie; Christopher L Drake
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

3.  Improved resilience following digital cognitive behavioral therapy for insomnia protects against insomnia and depression one year later.

Authors:  Philip Cheng; David A Kalmbach; Hsing-Fang Hsieh; Andrea Cuamatzi Castelan; Chaewon Sagong; Christopher L Drake
Journal:  Psychol Med       Date:  2022-03-08       Impact factor: 10.592

4.  The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial.

Authors:  Jingjing Zhou; Jian Yang; Xuequan Zhu; Tarek Zghoul; Lei Feng; Runsen Chen; Gang Wang
Journal:  Ther Adv Psychopharmacol       Date:  2020-07-01

5.  Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Authors:  Jingjing Zhou; Weiwei Wang; Jian Yang; Xuequan Zhu; Lei Feng; Le Xiao; Gang Wang
Journal:  Trials       Date:  2019-01-09       Impact factor: 2.279

6.  Optimization of measurement-based care (OMBC) for depression based on all-round and continuous assessment: rationale and protocol for a multicenter randomized control clinical trial.

Authors:  Jingjing Zhou; Xiao Wang; Jian Yang; Xuequan Zhu; Le Xiao; Lei Feng; Gang Wang
Journal:  Trials       Date:  2022-05-03       Impact factor: 2.728

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.